Lindbrook Capital, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Lindbrook Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$0.28 - $1.16 $296 - $1,229	-1,060 Reduced 51.46%	1,000 $0
Q1 2024 Apr 25, 2024	SELL	$1.06 - $1.67 $6,249 - $9,846	-5,896 Reduced 74.11%	2,060 $2,000
Q4 2023 Jan 31, 2024	SELL	$1.26 - $1.79 $229 - $325	-182 Reduced 2.24%	7,956 $13,000
Q3 2023 Oct 25, 2023	SELL	$1.61 - $2.54 $5,425 - $8,559	-3,370 Reduced 29.28%	8,138 $14,000
Q2 2023 Jul 28, 2023	BUY	$1.14 - $1.95 $4,970 - $8,502	4,360 Added 61.0%	11,508 $21,000
Q1 2023 Apr 26, 2023	BUY	$1.2 - $2.19 $8,221 - $15,003	6,851 Added 2306.73%	7,148 $9,000
Q4 2022 Jan 24, 2023	BUY	$1.63 - $3.52 $361 - $781	222 Added 296.0%	297 $0
Q3 2022 Nov 10, 2022	BUY	$0.73 - $3.74 $54 - $280	75 New	75 $0

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.